Application

15850253 · Treatment of Inflammation, Autoimmune, and Neurodegenerative Disorders with Immunosuppressive Tat Derivative Polypeptides

Filed 2017-12-21 · Abandoned The official file ↗ · Art unit 1648 · Examiner Jeffrey S Parkin Typical · CPC A61K 38/162 · PIN Pharma, Inc. · K & L Gates LLP-OC Admin

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

10.2 mo

to disposition 39.3 mo

Statutes raised

112

3 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.